Trasylol Attorney Missouri ~ APROTININ ~ Lawyer for Drug Recall

Contact Cardin & Payne for a free & prompt legal consultation about your Trasylol Lawsuit

Experts report Trasylol (drug generic name: Aprotinin) doubles the risk of kidney failure and stroke and increases the risk of heart failure or heart attack by 55 percent. Aprotinin/Trasylol is an injection during surgery (not an over-the-counter drug) used to prevent excessive blood loss during heart bypass surgery. Aprotinin is linked to causing encephalopathy, degenerative brain diseases.

Are you or a family member eligible for an Trasylol/Aprotinin lawsuit?

Aprotinin is the generic word for the brand name Trasylol.

It didn't have to be this way but GREED reared its ugly head.

The generic alternatives to Trasylol--Amicar (aminocaproic acid) and Cyklokapron (tranexamic acid)--were studied as well. These generic drugs were confirmed through thes studies to be both safe and effective. Expert researchers estimate that if hospitals stopped using Trasylol promptly and instead used the above generic drugs, it would save 9,000 to 11,000 people every year from kidney dialysis.

Greed explained:

The difference in bypass surgery drugs is alarming:
-Trasylol costs $1,300 per dose (manufactured by Bayer AG)
-Amicar costs only $11 per dose (generic)
-Cyklokapron costs $44 per dose (generic)

Bayer made BIG money as a result of deception and malice.

In January 2006, the New England Journal of Medicine published a report about a study revealing the dangerous Trasylol/aprotinin side effects. The maker of Trasylol, Bayer AG, insisted the study was flawed and that the Trasylol is safe.

Eight months later Bayer chose to not disclose the dangers of two recent aprontinin studies to the FDA. On September 29, 2006 Bayer said it had mistakenly (and an oddly fortuitous mistake for Bayer) withheld another study based on 67,000 hospital patient records that suggested the drug could increase the chances of death, serious kidney damage, congestive heart failure, and stroke. Bayer only disclosed their own report and these serious facts after a whistle-blower contacted the Food and Drug Administration (FDA).

If these reports had not come out and the evidence revealed, it could have gotten much worse. What’s really horrifying is that Bayer had been hoping that Trasylol would be used in all types of surgeries.